Marinus Pharmaceuticals
About:
Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders.
Website: http://www.marinuspharma.com
Twitter/X: marinuspharma
Top Investors: Oaktree Capital Management, Bain Capital Life Sciences, Canaan Partners, Sofinnova Investments, Domain Associates
Description:
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.
$452M
$10M to $50M
Branford, Connecticut, United States
2003-01-01
info(AT)marinuspharma.com
Harry H. Penner
101-250
2022-11-07
Public
© 2025 bioDAO.ai